Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) stock is trading higher on Tuesday after the company announced that it secured U.K. regulatory clearance for its key wound care and dermatology products.
The Details: Sonoma received clearance from the Medicines & Healthcare products Regulatory Agency for five products, including its hypochlorous acid-based wound irrigation solution, scar management products, wound hydrogel and skin exfoliant.
“Thanks to the diligent efforts of our regulatory team in securing these new registrations with the MHRA, we are now able to bring our safe and effective Microcyn-based products to the United Kingdom,” said Amy Trombly, CEO of Sonoma.
“The U.K. represents a significant new market for Sonoma, for both our wound care and dermatology products, and we are excited for the opportunities for growth that this new registration provides.”
See Also: Why Is Jeffs Brands Surging Premarket On Tuesday?
SNOA Price Action: At the time of writing, Sonoma shares are trading 17.6% higher at $3.24, according to data from Benzinga Pro.
Image: This illustration was generated using artificial intelligence via Midjourney.